โ† All COPR Flashcard Decks

COPR - Canadian Organization of Paramedic Regulators Examination Pharmacology and Medication Administration Questions and Answers Flashcards

6 cards from real COPR practice questions. Tap to flip, then mark Knew It or Still Learning โ€” missed cards come back until you master them.

Read the first 6 COPR - Canadian Organization of Paramedic Regulators Examination Pharmacology and Medication Administration Questions and Answers flashcards as text
  1. A paramedic administers epinephrine 1:1000 IM for anaphylaxis. What is the standard adult dose?

    Answer: 0.3 mg

    The standard adult IM dose of epinephrine 1:1000 for anaphylaxis is 0.3 mg (0.3 mL) in the anterolateral thigh.

  2. Which pharmacological mechanism describes nitroglycerin's primary action in chest pain management?

    Answer: Venodilation reducing cardiac preload

    Nitroglycerin primarily acts as a venodilator, reducing venous return and cardiac preload, thereby decreasing myocardial oxygen demand.

  3. When administering adenosine for SVT, what is the correct initial adult IV dose?

    Answer: 6 mg rapid IV push

    The initial adult dose of adenosine for SVT is 6 mg administered as a rapid IV push, followed immediately by a 20 mL saline flush.

  4. A patient with suspected opioid overdose is unresponsive with a respiratory rate of 4/min. Which drug should be administered?

    Answer: Naloxone

    Naloxone (Narcan) is the opioid antagonist used to reverse opioid-induced respiratory depression.

  5. Which route of medication administration provides the fastest onset of action?

    Answer: Intravenous

    Intravenous administration delivers drugs directly into the bloodstream, providing the fastest onset of action compared to all other routes.

  6. Aspirin is given to a patient with suspected STEMI primarily because it:

    Answer: Inhibits platelet aggregation to reduce clot formation

    Aspirin irreversibly inhibits COX-1, blocking thromboxane A2-mediated platelet aggregation to help prevent further thrombus growth in STEMI.